UNRESECTABLE ADRENAL CORTEX CARCINOMA

Clinical trials for UNRESECTABLE ADRENAL CORTEX CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new UNRESECTABLE ADRENAL CORTEX CARCINOMA trials appear

Sign up with your email to follow new studies for UNRESECTABLE ADRENAL CORTEX CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New Two-Drug attack on rare, aggressive adrenal cancer

Disease control Recruiting now

This study is testing whether combining two existing drugs, cabozantinib and pembrolizumab, can help control advanced adrenal cancer. It is for adults whose cancer has spread or cannot be removed by surgery. The goal is to see if this combination can shrink tumors and stop the ca…

Matched conditions: UNRESECTABLE ADRENAL CORTEX CARCINOMA

Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control

Last updated Mar 31, 2026 12:11 UTC

UNRESECTABLE ADRENAL CORTEX CARCINOMA

Get alerted when new UNRESECTABLE ADRENAL CORTEX CARCINOMA trials appear

New Two-Drug attack on rare, aggressive adrenal cancer